On a weekday at Calgary’s Bow Valley College, James Cairns moves from a meeting on AI governance to a hallway chat with ...
Pioneering CRISPR trial shows single infusion permanently lowers bad cholesterol by 50% in patients who don't respond to medication.
Dangerously high levels of “bad” cholesterol and triglycerides may be reduced by gene editing, in what study researchers hope ...
Researchers report early but encouraging results on an experimental gene-editing treatment for high cholesterol.
An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...
In a phase 1 trial, a gene-editing therapy that targets ANGPTL3 was associated with few serious adverse events and at higher ...
A cutting-edge medical experiment in a small trial has demonstrated the effectiveness of a one-time CRISPR gene editing treatment in lowering cholesterol levels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results